scispace - formally typeset
Search or ask a question

How much does estrogen cost in India? 

Answers from top 12 papers

More filters
Papers (12)Insight
Collectively, these methods can be used to better determine estrogen loads from CAFO operations, and this research shows that estrogen conjugates contribute significantly to the overall estrogen load, even in different types of CAFO lagoons.
While these indicative cost-effectiveness estimates can inform HIV control planning currently, the wide uncertainty range around estimates for several interventions suggest the need for more firm data for estimating cost-effectiveness of HIV prevention interventions in India.
The morbidities cost per illness episode were inevitably increased in the last decade in India.
An estrogen advantage hypothesis is put forth that provides a unifying mechanism of estrogen action with implications for both the benefits and risks of estrogen therapy
Use of trastuzumab for 1 year is not cost effective in India at the current price.
Journal ArticleDOI
R. X.-D. Song, Richard J. Santen 
01 Jan 2003-Apoptosis
109 Citations
The effects of estrogen are estrogen-receptor dependent.
There is wide variation in the cost of various statins available in India, which increases the economic burden on patients.
Selection factors for use of estrogen are evident and may introduce bias in studies of estrogen and disease.
The morbidity and cost associated with these outcomes may need to be considered in decisions regarding the use of estrogen therapy.
Low-dose esterified estrogen improved hemodynamic patterns similar to standard doses of conjugated equine estrogen in postmenopausal women.
In this cost-effectiveness analysis using previously published clinical data and year-2003 cost data from a community hospital in the Italian National Health Service, anastrozole and letrozole were both cost-effective alternatives to tamoxifen for first-line therapy of postmenopausal women with advanced estrogen receptor-positive breast cancer.
Journal ArticleDOI
Emad Ali, Cheyenne Mangold, Alan N. Peiris 
01 Sep 2017-Menopause
33 Citations
We conclude transvaginal estriol potentially offers a suitable physiologic delivery and cost-effective alternative to currently available estrogen regimens in selected patients.